ライフサイエンスコーパス: patient with

1 , small sample size, and examination of only patients with 1-year outcome data.

2 lovian threat-conditioning paradigm in eight patients with a bilateral vmPFC lesion, 10 with a lesion

3 s were driven by TCR clusters shared between patients with a characteristic trajectory of clonotypes

4 ure AML or significantly extend the lives of patients with a common mutation called FLT3-ITD.

5 Methods: In total, 37 patients with a confirmed STS of the extremities underwe

6 Patients with a contained duodenal diverticular perforat

7 The secondary group consisted of patients with a history of brain radiation therapy or cr

8 We conducted a postal survey of adult patients with a history of physician-diagnosed Sjogren s

9 All records from patients with a minimum of 6 months of follow-up and at

10 wo cycles of blinatumomab; the percentage of patients with a molecular response increased further aft

11 Excluding patients with a need or likely need for laser or surgery

12 Methods: Ten patients with a peripheral AVM (mean age, 40 y; 4 men an

13 Methods: Five patients with a prior diagnosis of breast cancer, renal

14 in dorsal ACC (p = .03), and the subgroup of patients with a schizophrenia diagnosis had higher gluta

15 roach, based on cross-reactivity studies, in patients with a suspicion of BL hypersensitivity and an

16 retrospective chart review was conducted on patients with a T2Candida panel and mycolytic/fungal (my

17 aregiver cost of illness information for 395 patients, with a median cost of illness per case of $59.

18 We characterized 506 patients with ABCA4 variants using conventional genetic

19 AACC (Continuous Positive Airway Pressure in Patients with ACS and OSA) study, including 1,701 patien

20 re hospitals in eight countries, we enrolled patients with acute ischaemic stroke due to large vessel

21 Malnutrition is common in patients with acute kidney injury (AKI) and the risk of

22 tem cell transplantation (HSCT) in pediatric patients with acute lymphoblastic leukemia (ALL) is effi

23 A-A2) that has been observed in about 35% of patients with acute myeloid leukaemia (AML).

24 hase complete CIV control was more likely in patients with acute-phase complete CIV control (RR, 1.19

25 SFCT was similar among patients with AD and MCI and control subjects on multiva

26 ating lymphocytes (TILs) for treating cancer patients with adoptive cell therapy.

27 Estrogen therapy is effective in treating patients with advanced BC after resistance to TAM and ar

28 ble-blind, parallel-group, randomised trial, patients with advanced cancer, aged at least 18 years, a

29 l enrollment using ctDNA sequencing in 1,687 patients with advanced gastrointestinal (GI) cancer in S

30 th the clinical failure of AR antagonists in patients with advanced HCC by evaluating potential resis

31 We randomly assigned 777 patients with advanced kidney disease and moderate or se

32 FOLFIRINOX has become a standard therapy for patients with advanced PDAC and can be used to potential

33 ion status and as predictors of 5-year OS in patients with advanced-stage CRC.Keywords: Abdomen/GI, C

34 Proportions of patients with adverse events did not differ significantl

35 sed in clinical practice, particularly among patients with alcohol-associated or NASH-related cirrhos

36 In patients with an indication for an ICD but no indication

37 on individual cardiovascular outcomes and in patients with and without history of atherosclerotic car

38 isk of cardiovascular death was observed for patients with and without postoperative AF (incidence ra

39 Patients with anemia and lower-risk myelodysplastic synd

40 aim was to demonstrate that antibodies from patients with anti-N-methyl-d-aspartate receptor (NMDAR)

41 On average, patients with anxiety reported an additional 2.64 (95% C

42 rquartile range {IQR} 0-1] vs 1 [IQR 0-2] in patients with any positive BDG test; P = .039).

43 n diastolic dysfunction (DD) and outcomes in patients with aortic stenosis undergoing transcatheter a

44 ther such Crs-based phenotypes existed among patients with ARDS before the COVID-19 pandemic and to c

45 ethods: We undertook a secondary analysis of patients with ARDS, who were invasively ventilated on co

46 most abundant bacteria found on the skin of patients with atopic dermatitis (AD).

47 nd other adjacent structures are frequent in patient with atrial fibrillation (prevalence: 13.5%).

48 rinking, real-world behavior was assessed in patients with AUD at baseline and for 4 weeks following

49 e HUNT, M-BERET, and Kunzmann tools identify patients with BE with AuROC values ranging from 0.665 to

50 rs of down-staging, and the impact of LRT in patients with beyond-MC HCC from the U.S. Multicenter HC

51 We identified five patients with biallelic variants in EXOSC5, which encode

52 Patients with bilateral infiltrates more often had a pri

53 mbrane antigen (PSMA)-targeted PET agent, in patients with biochemically relapsed prostate cancer aft

54 d patient and caregiver information for 1029 patients with blood culture-confirmed enteric fever or w

55 evident in patients with favorable outcomes; patients with BSP and unfavorable outcomes showed either

56 To date, ~50% of patients with bvFTD receive a prior psychiatric diagnosi

57 ndependent risk factor for mortality in both patients with CACLD (adjusted hazard ratio, 7.4; 95% con

58 In Mks from patients with CALR-mutated MPNs, defective interactions

59 We generated individualised risk tables for patients with cancer, considering age, sex, and tumour s

60 ent smoking may cause adverse outcomes among patients with cancer.

61 We identified 98 783 hospitalized patients with candidemia; 529 patients (0.5%) had concur

62 oration of sEVs between healthy controls and patients with CAP or AECOPD.

63 esponse syndrome (SIRS) frequently occurs in patients with cardiogenic shock and may aggravate shock

64 in practice to assess endoscopic activity in patients with CD.

65 udy differences between healthy controls and patients with celiac disease (CD).

66 Methods: Forty-three patients with cerebral gliomas (9 low-grade, 34 high-gra

67 hepatocellular carcinomas (HCCs) develop in patients with chronic hepatitis, which creates a microen

68 Patients with chronic lung disease (other than asthma) w

69 um/vilanterol (FF/UMEC/VI) versus UMEC/VI in patients with chronic obstructive pulmonary disease (COP

70 Twenty healthy volunteers and 70 patients with circulatory shock (< 12 hr duration), defi

71 ized with stool from controls (Ctrl-Hum) and patients with cirrhosis (Cirr-Hum).

72 We investigated the gut microbiome in patients with cirrhosis encompassing the whole spectrum

73 arterial pressure is critically important in patients with cirrhosis in the ICU, however, there is li

74 Included were 300 adult patients with cirrhosis who underwent outpatient physica

75 s, might mediate parenchymal renal injury in patients with cirrhosis, suggesting that concurrent mech

76 ight contribute to the development of AKI in patients with cirrhosis.

77 Patients with CKD are at an increased risk (compared wit

78 dietary sodium restriction in reducing BP in patients with CKD stage G3 or G4 and hypertension, we co

79 Seventy-seven pediatric patients with clinically confirmed fish allergy underwen

80 rds, fundus photographs, and OCT imaging for patients with CLN2 disease collected during examinations

81 icacy of the JAK1/2 inhibitor ruxolitinib in patients with CNL and aCML, irrespective of CSF3R mutati

82 ly stratified treatment options available to patients with colorectal cancer (CRC) is increasing, wit

83 types and between PIV and other pathogens in patients with community-acquired pneumonia.

84 e T cells had the capacity to respond, older patients with comorbidity had larger numbers of activate

85 endent predictor of mortality at 10 years in patients with complex coronary artery disease.

86 Conclusion In patients with confirmed coronavirus disease 2019 pneumon

87 In this meta-analysis of patients with COPD and hypercapnia, home BPAP, compared

88 successfully restore the reading ability in patients with corneal diseases, which is a crucial part

89 ) has been observed to improve the health of patients with coronary artery disease (CAD).

90 therapeutic strategies in the management of patients with COVD-19.

91 valence of pulmonary embolisms was higher in patients with COVID-19 (26% vs. 16.3% in patients withou

92 492 pulmonary CT angiograms (342 (69.9%) in patients with COVID-19 and 147 (30.1%) in patients witho

93 In particular, thrombotic complications in patients with COVID-19 are common and contribute to orga

94 In patients with COVID-19 who received ECMO, both estimated

95 ected from seven clinical areas, occupied by patients with COVID-19, and a public area of the hospita

96 -CoV-2 infection, similar to what is seen in patients with COVID-19.

97 hibitors or angiotensin receptor blockers in patients with COVID-19.

98 iveness and harms of remdesivir treatment in patients with COVID-19.

99 sk gene ATG16L1 and Paneth cell lysozymes in patients with Crohn's disease.

100 lowest presuppression CD4 count >=200 (56%), patients with current CD4 351-500 vs >500 cells/muL had

101 l ganglia and thalamus, we demonstrated that patients with current history presented increased intera

102 Patients with DAP1 risk allele exhibit significantly hig

103 odern-era" validation study that included 99 patients with definitive PVN transplanted post January 1

104 One hundred four patients with degenerative mitral regurgitation surgical

105 nsight into brain-behaviour relationships in patients with dementia.

106 regulation in postmortem cortical samples of patients with depression.

107 ual information on emotional attributions in patients with depression.

108 FA (UWFA) and more challenging situations in patients with developmental delay.

109 compared the risk of Parkinson's disease in patients with diabetes exposed to thiazolidinediones (gl

110 preclinical models of diabetes mellitus and patients with diabetes mellitus facilitating the bi-dire

111 preexisting complications or pathologies in patients with diabetes might aggravate infection course.

112 raw conclusions about how many years earlier patients with diabetes reach the 10-year cumulative risk

113 levation in C5a activity was demonstrated in patients with diabetes; conventional renoprotective agen

114 the effect of OSA on cardiovascular risk for patients with different ACS phenotypes.Methods: Post hoc

115 rences in fecal microbiota composition among patients with different IBS symptom subtypes.

116 comparison made between normal patients and patients with dissection, right CCA (p = 0.000), ICA (p

117 the clinical benefits of these treatments in patients with diverse cancers.

118 could meaningfully improve long-term care of patients with DLBCL.

119 sed risk of acute cerebrovascular disease in patients with dual infection merits further investigatio

120 erived glycation free adducts were higher in patients with early decline in GFR, compared to those wi

121 hibits an improved rate of seropositivity in patients with early Lyme infection.

122 anging from 0.665 to 0.695, and discriminate patients with early neoplasia from patients without BE w

123 Furthermore, patients with early-stage breast cancer who experienced

124 gical disorder affecting almost 40% of adult patients with epilepsy.

125 lues determined in healthy volunteers and in patients with esophageal cancers.

126 Patients with established coronary artery disease or per

127 platelet activation in the vast majority of patients with ET.

128 In this pilot study patients with FA exhibited a disease-specific metabolomi

129 evaluating the clinical efficacy of PCCs in patients with factor Xa inhibitor-related ICH are needed

130 re identified by whole-exome sequencing of 2 patients with familial IMD.

131 urst theta spectral features were evident in patients with favorable outcomes; patients with BSP and

132 among 84,479 unique subjects with IHD (2,103 patients with FH) on the basis of 28 studies, 6.7% (95%

133 16 unique subjects with premature IHD (1,471 patients with FH) on the basis of 32 studies, and 7.2% (

134 e subjects in the general population (33,036 patients with FH) on the basis of 44 studies, 3.2% (95%

135 bjects with severe hypercholesterolemia (920 patients with FH) on the basis of 7 studies.

136 Herein, we propose a method to detect patients with fibromyalgia (n = 252, 126 controls and 12

137 fibromyalgia (n = 252, 126 controls and 126 patients with fibromyalgia) through the analysis of thei

138 Key proportions of patients with findings of pulmonary infection and those

139 Using data from patients with focal brain damage, we demonstrate that th

140 fferences in cognition and behaviour between patients with FTD-ALS and bvFTD alone.

141 ked to lowered intraocular pressure (IOP) in patients with glaucoma, ocular hypertension, anatomic na

142 rix Cluster 3), indicated poorer survival in patients with grade III tumors.

143 Patients with granuloma or moderate-severe ileitis on bi

144 19 away from it (2 cases unclear location; 7 patients with >1 recurrence).

145 safety, and tolerability of berotralstat in patients with HAE over a 24-week treatment period (the p

146 of tolerability is increasingly relevant for patients with haematological malignancies treated with c

147 are likely to optimise end-of-life care for patients with haematological malignancies.

148 hospitalization and cardiovascular death in patients with heart failure and reduced ejection fractio

149 linical features correlated with NAFLD among patients with heart failure with preserved ejection frac

150 iding high-quality care to a large cohort of patients with heart failure, heart transplantation, and

151 howed encouraging efficacy as monotherapy in patients with heavily pretreated multiple myeloma in the

152 We randomly assigned patients with HER2-positive metastatic breast cancer pre

153 It has been shown that patients with HFpEF develop B-lines upon submaximal exer

154 Contrary to our hypothesis, patients with HFpEF displayed impaired cardiac beta-rece

155 and renal outcomes in all randomly assigned patients with HFrEF and in relevant subgroups from DAPA-

156 of cardiac implantable electronic devices in patients with HFrEF on the basis of individual noninvasi

157 tedanib might provide therapeutic benefit in patients with HHT.

158 retrospective arm of this study included 146 patients with histologically confirmed stage IIIB-IV NSC

159 All patients with histologically verified primary or seconda

160 efects in cardiomyopathy-associated genes in patients with HLHS, which may portend impaired functiona

161 m safety and efficacy data for evolocumab in patients with homozygous FH (HoFH) and severe heterozygo

162 tly associated with COVID-19 diagnosis among patients with hypertension or with mortality or severe d

163 One hundred eighty-three patients with hypertrophic cardiomyopathy and a low- or

164 We gathered information on 94 patients with IEI with SARS-CoV-2 infection.

165 ement of pancreatic necrosis is indicated in patients with infected necrosis.

166 neral population cohort to as high as 78% in patients with inflammatory bowel disease(2).

167 ing and monitoring vision-related anxiety in patients with inherited retinal degenerations.

168 Early discrimination of patients with ischemic stroke (IS) from stroke mimics (S

169 Meta-analysis of patients with isoniazid-resistant tuberculosis (TB) give

170 lar events are the leading cause of death in patients with JAK2V617F myeloproliferative neoplasms (MP

171 ) cells was identified in lung and uterus of patients with LAM, sharing close transcriptomic identity

172 Clinical features from 87 patients with LEMS, occurring within three months from d

173 ved in the diagnosis, management and care of patients with LGMDR3-6 created a European Sarcoglycanopa

174 Information about where patients with limited health insurance receive maintenan

175 ng (WGS) and develop a model that identifies patients with long survival.

176 Twenty-seven patients with low CrAg titers were treated with antifung

177 Among patients with lowest presuppression CD4 count >=200 (56%

178 the most important predictor of survival in patients with LRRC.

179 rns of whole-body (18)F-FDG PET/CT images in patients with lung cancer and lymphoma.

180 due to HIV to inform treatment strategies in patients with M. tuberculosis/HIV coinfection.

181 In the 81 patients with MD, Becker was the most common type (42%-5

182 ide therapy can lead to bowel obstruction in patients with mesenteric or peritoneal disease, likely b

183 Few effective treatments are available for patients with metastatic MCC.

184 nd of matched metastatic tumor biopsies from patients with metastatic prostate adenocarcinoma and CRP

185 in amyloid-beta-negative participants, or in patients with mild cognitive impairment who did not conv

186 -CoV-2-specific T cells in 10 of 10 COVID-19 patients with mild symptoms.

187 1554 patients with mild-to-severe TBI were assessed at 6 mont

188 Patients with MMR-deficient colorectal cancer were exclu

189 Compared to patients with moderate COVID-19, patients with severe CO

190 corticosteroids (ICSs) has been reserved for patients with more persistent asthma.

191 urrent understanding derived from studies of patients with MS and animal models of how specific cytok

192 alomyelitis (EAE), substantial evidence from patients with MS points to a role for CD8+ T cells in di

193 in magnetic resonance imaging departments in patients with MS, which include new data and practical c

194 inically meaningful and durable responses in patients with mUC; survival data are encouraging.

195 even when they had been exposed to an index patient with multidrug-resistant tuberculosis.

196 timorbidity patterns may reduce mortality in patients with multimorbidity.

197 Consecutive patients with nAMD received anti-VEGF therapy according

198 n associated with regular IVT injections for patients with nAMD.

199 In patients with negative [TIMP-2]*[IGFBP7] at baseline, th

200 some lesions resembled findings reported in patients with NiV infection.

201 ons of GS and GFAP were measured by ELISA in patients with NMOSD (n=39, 28 aquaporin-4 (AQP4)-Ab-sero

202 Patients with NMRs >= 5.75 after the first cycle had sig

203 Patients with nonischemic HF were randomized to routine

204 rsus placebo and narrowband-ultraviolet B in patients with nonsegmental vitiligo.

205 agonist plus aspirin and P2Y12 inhibitor) in patients with nonvalvular atrial fibrillation (AF) after

206 ium channel blockers are reasonable drugs in patients with normal ventricular systolic function.

207 he context of risk-adapted therapy for young patients with NRSTS.

208 Patient/study population: patients with NVAMD.

209 After stabilization, patients with NVUGIB should undergo endoscopy with endos

210 Patients with opioid use disorder (OUD) who are hospital

211 First- or second-degree blood relatives of a patient with ovarian cancer with a known germline pathog

212 Improvements in the outcomes of patients with pancreatic ductal adenocarcinoma (PDAC) ha

213 Patients with pancreatic ductal adenocarcinoma (PDAC) ha

214 For all patients with Parkinson disease, treatment is symptomati

215 Patients with Parkinson's disease who had 2 h or more of

216 th persistent AF had more comorbidities than patients with paroxysmal AF.

217 lly, the age at onset of Parkinson's disease patients with pathogenic/likely pathogenic variants in A

218 nitive performance over 1, 2, and 4 years in patients with PD.

219 eral nutrition (EEN) can induce remission in patients with pediatric Crohn's disease (CD).

220 pression were significantly downregulated in patients with peri-implantitis in comparison with peri-i

221 Patients with peripheral artery disease (PAD) have a hig

222 was the most common comorbidity (67.6%), and patients with persistent AF had more comorbidities than

223 Patients with PEX achieved a lower maximal workload (PEX

224 t been validated in a well-defined cohort of patients with PG.

225 nge studies may also aid decision-making for patients with PH-LHD or otherwise unexplained dyspnea.

226 ve medications is recommended for some older patients with polypharmacy and multimorbidity when the b

227 Patients with postthrombotic femoral veins and those who

228 Patients with prior stroke had a higher stroke severity

229 fixed coronal hemispheric brain slices of 23 patients with progressive multiple sclerosis directly af

230 Importantly, patients with psoriasis displayed reduced activation of

231 antagonist, on explanted lesional skin from patients with psoriasis.

232 ssel densities were significantly reduced in patients with PXG compared with patients with PXS and no

233 y reduced in patients with PXG compared with patients with PXS and normal control subjects (all P < .

234 , and circulating markers of inflammation in patients with quiescent IBD.

235 survival was significantly different between patients with R0 versus R1 margins but wider resection m

236 RR of death comparing patients with recent systemic anticancer therapy to no t

237 n (DBS) is an effective treatment option for patients with refractory obsessive-compulsive disorder (

238 Overall survival in patients with relapsed disease remains poor, and thus no

239 d had a manageable adverse events profile in patients with relapsed or refractory DLBCL who received

240 er MAR confers long-term benefit over SAR in patients with renal dysfunction who require CABG.

241 educed the risk of relapse versus placebo in patients with resected, BRAF(V600)-mutant, stage III mel

242 therapies was 4.1%, 5.3%, 9.5%, and 13.3% in patients with, respectively, 0, 1, 2, or >=3 guidelines-

243 col for repeated home collection of blood in patients with rheumatoid arthritis to allow for longitud

244 rception along the blue-yellow axis in blind patients with RP by electrically stimulating the retina.

245 Pseudophakic patients with RRD managed with PPV or PPV-SB were analyz

246 e, observational study of adult hospitalized patients with SAB.

247 Eighty-two Dutch patients with SCA3/MJD were evaluated annually for 15 ye

248 Adult patients with scaphoid waist fractures displaced by 2 mm

249 trospective single-center study in all adult patients with SD admitted to a tertiary intensive care u

250 Identification and outcomes in patients with sepsis have improved over the years, but l

251 e Corticosteroid Treatment in Critically Ill Patients with Septic Shock) and $30,911 (Activated Prote

252 mpare echocardiographic findings in low-risk patients with severe aortic stenosis after surgical aort

253 Compared to patients with moderate COVID-19, patients with severe COVID-19 had higher peak white bloo

254 Comparing outcomes of MMCR vs ELR in patients with severe ptosis, there was a statistically s

255 iferol also suppressed intact PTH only among patients with severe vitamin D deficiency.

256 Most patients with SMPE were treated with embolectomy (98.9%

257 with (177)Lu-labeled somatostatin analogs in patients with somatostatin receptor-expressing tumors is

258 ution in order to create a cohort of virtual patients with some specific characteristics, resembling

259 in autophagy in colonic mucosal tissues from patients with sporadic CRC colonized with vs without CoP

260 Few studies have evaluated RDV in patients with SRI due to theoretical toxicity concerns.

261 rformance and safety in a phase III study of patients with SSTR-expressing NETs.

262 ime is a newly available process measure for patients with ST-segment-elevation myocardial infarction

263 esigned to detect improvement in outcomes of patients with stage II to IV DAWT compared with historic

264 predisposition to cancer is warranted in UM patients with strong personal or family history of cance

265 ne a practical approach to the evaluation of patients with suspected autoinflammation.

266 BEST PRACTICE ADVICE 6: Patients with suspected celiac disease who are seronegat

267 Second, among 1,460 patients with suspected sepsis (sepsis-2 definition), BC

268 More than 30% of patients with symptomatic cholecystolithiasis reports pe

269 In comparison with patients with T1MI, patients with T2MI had higher long-t

270 In comparison with patients with T1MI, patients with T2MI had higher long-term all-cause mortal

271 Patients with tetralogy of Fallot and an ICD experience

272 Patients with the neurological syndrome known as body in

273 er risk for transplant failure compared with patients with the same duration of pretransplant dialysi

274 ovide evidence that abnormalities in GPHYSD1 patients with this mutation are caused by loss of O-fuco

275 ively target endocan-EGFR regulatory axis in patients with TKI-resistant NSCLC.

276 re the only two oral chelators used in adult patients with transfusion-dependent haemoglobinopathies.

277 the years, but little data are available in patients with trauma who develop sepsis.

278 therapy with a manageable safety profile in patients with treatment-naive, or relapse or refractory

279 therapeutic promise of TRPV4 antagonists for patients with TRPV4-related neurodegenerative diseases.

280 Patients with tumour mutational burden in the lower two

281 ric procedures should also be considered for patients with type 2 diabetes and a body mass index of 3

282 ble-blind, placebo-controlled trial included patients with type 2 diabetes and urine albumin-to-creat

283 alization for HF and cardiovascular death in patients with type 2 diabetes mellitus.

284 ned effect on lung function, particularly in patients with type 2 phenotype.

285 In 14 patients with typical RTT, 9 epilepsy control patients,

286 Patients with UEL appear to have a more substantial redu

287 For patients with ulcerative colitis, Eubacterium rectale an

288 HLH can also occur in patients with underlying rheumatologic or autoinflammato

289 dative neovascular AMD in the fellow eyes of patients with unilateral exudative AMD ranged from 6.25%

290 +)) increase in number in the circulation of patients with unstable coronary artery disease (CAD), an

291 during R-CHOP-14 does not improve outcome in patients with untreated DLBCL.

292 Results: Of 21 patients with UrC-ADC before (18)F-FDG PET/CT, Mayo stag

293 Patients with USBR had lower 3-year risk of subsequent a

294 eplacement has been the standard of care for patients with valvular heart disease for many decades, b

295 ecently, birth defects have been observed in patients with variants in the gene encoding a member of

296 the lamin A/C gene (LMNA) are identified in patients with various types of laminopathy-containing di

297 health care quality among "superutilizers," patients with very high use of health care services.

298 Sixty patients with VSD aged 12 to 60 years underwent cardiopu

299 , a novel highly selective BTK inhibitor, in patients with WM.

300 and joint stiffness appear less commonly in patients with WMS4 caused by pathogenic ADAMTS17 variant